te comprising any organic carrier and a purified lipid cell-wall component associated therewith in a method of making a medicament for use in enhancing resistance or lowering susceptibility to inflammatory conditions and/or allergies in a subject. [0072] The organic carrier may be a protein including bovine serum albumin (BSA), gelatin, keyhole limpets haemocyanin, the CD1 molecule and a serum pro